Authors: Baril, L Beucler, I Valantin, MA Bruckert, E Bonnefont-Rousselot, D Coutellier, A Caumes, E Katlama, C Bricaire, F

Citation: L. Baril et al., Low lipolytic enzyme activity in patients with severe hypertriglyceridemiaon highly active antiretroviral therapy, AIDS, 15(3), 2001, pp. 415-417

Authors: Delaugerre, C Valantin, MA Mouroux, M Bonmarchand, M Carcelain, G Duvivier, C Tubiana, R Simon, A Bricaire, F Agut, H Autran, B Katlama, C Calvez, V

Citation: C. Delaugerre et al., Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure, AIDS, 15(16), 2001, pp. 2189-2191

Authors: Mouroux, M Izopet, J Descamps, D Delaugerre, C Yvon-Groussin, A Angleraud, F Coutellier, A Bonmarchand, M Valantin, MA Matheron, S Agut, H Katlama, C Brun-Vezinet, F Calvez, V

Citation: M. Mouroux et al., Conditions of selection of 'thymidine analogue mutations' (TAMs) in naive patients receiving different antiretroviral combinations including d4T., PATH BIOL, 48(5), 2000, pp. 508-512

Authors: Mouroux, M Bossi, P Yvon-Groussin, A Delaugerre, C Valantin, MA Tubiana, R Coutellier, A Bonmarchand, M Bricaire, F Katlama, C Agut, H Huraux, JM Calvez, V

Citation: M. Mouroux et al., Protease gene polymorphism in HIV-1-infected patients and response to therapy including a protease inhibitor., PATH BIOL, 47(5), 1999, pp. 549-552